Patients with newly diagnosed advanced ovarian cancer who experienced disease progression had worse health-related quality of life (HRQOL), according to data from the PRIMA/ENGOT-OV26/GOG-3012 trial of first-line maintenance therapy with…

Patients with newly diagnosed advanced ovarian cancer who experienced disease progression had worse health-related quality of life (HRQOL), according to data from the PRIMA/ENGOT-OV26/GOG-3012 trial of first-line maintenance therapy with…